A Terzo Tempo choir of about 70 teenagers and adults performed at Milan's Sant'Antonio church on Feb. 18, calling for harmony and inclusion as the Winter Paralympics approach; the Archdiocese of Milan created a branch in 2021 to raise awareness of inclusion.
FedEx has sued the U.S. government asking to be repaid tariffs it paid after the Supreme Court found those tariffs unconstitutional; the article mentions other companies are pursuing similar refunds and lower courts will handle claims.
Robert Carradine, known for roles in Lizzie McGuire and Revenge of the Nerds, has died at 71, his family said. They noted he had struggled for nearly two decades with bipolar disorder and asked for privacy.
People gathered at Calgary city hall to mark four years since Russia's 2022 invasion of Ukraine, and many local Ukrainians described how displacement has changed their lives and sense of home.
A University of Winnipeg team is sequencing viruses that infect microalgae in Lake Winnipeg; analysis is ongoing and initial results show diverse viruses including larger "giant viruses".
Metrolinx is building a standalone chimney at 500 Howard Street in Oshawa as an environmental requirement during Simcoe Street bridge reconstruction, and the work is scheduled to finish April 3.
The Canadian Queer Chamber of Commerce has launched The FAM Program to provide a national professional network, events, and resources for 2SLGBTQI+ business owners across Canada, with free membership offered until March 31, 2026.
A Utah judge will rule on whether prosecutors should be disqualified from the case of the man accused of killing Charlie Kirk because a prosecutor's daughter witnessed the shooting; a preliminary hearing is tentatively scheduled for mid‑May.
On the fourth anniversary of Russia's invasion, Ukrainian President Volodymyr Zelenskyy warned that 'Putin will not stop' and urged allies to keep supporting Ukraine as Russian attacks on energy infrastructure continue; Kyiv is also managing a reported corruption scandal that has led to senior resignations.
Axsome Therapeutics has initiated the CLARITY Phase 3 trial studying solriamfetol in adults with major depressive disorder who experience excessive daytime sleepiness; the company's press release includes standard forward-looking statements and associated risks.
